Global nanobodies market is expected to grow at a significant rate in the forecast period. Nanobodies can be defined as antibody fragments and are made up of target-binding fragments of monoclonal antibodies. These are smaller in size than the traditional monoclonal antibodies and possess enhanced chemical properties. Nanobodies have high affinity and can specifically target the antigens with low-off target accumulation owing to their hydrophilic regions. Nanobodies are robust in nature and possess a high folding capacity. They can tolerate high temperatures and pressure, the strongest chemical denaturants, and non-physiological pH. The rise in the occurrence of cancer and the growing mortality rate from the patients suffering from it is influencing the growth of the global nanobodies market. Nanobodies are also vital in the early diagnosis of cancer as they ensure minimal non-target retention by creating a high tumor-to-background ratio just shortly after administration. The early diagnosis helps in providing effective treatment and decide the best course of action suitable according to the present condition of patients. Huge healthcare expenditure by the leading authorities and the market players to invest in the research and development activities is expected to influence the market growth. The success of the clinical trials of various nanobody products and their subsequent approvals are expected to fuel the nanobodies market growth.

Global nanobodies market is segmented into type, application, distribution channel, regional distribution, and company. Based on the regional analysis, North America is expected to dominate the market followed closely by Europe in the forecast period, 2022-2026. The presence of well-developed healthcare infrastructure and the huge healthcare expenditure is influencing the nanobodies market growth in the region. Favorable reimbursement policies for availing healthcare services and the growing health-consciousness among consumer is expected to boost the market growth in the next five years.

The major players operating in the global nanobodies market are Novo Nordisk A/S, Merck & Co., Inc., AbbVie, Inc., C.H. Boehringer Sohn AG & Ko. KG., Sanofi S.A. (Ablynx), Hybrigenics Services, Beroni Group, Shenzhen Kangti Co., Ltd. (Alphalife), among others. Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022–2026

Objective of the Study:

  • To analyze the historical growth of the market size of global nanobodies market from 2016 to 2019.
  • To estimate and forecast the market size of global nanobodies market from 2020 to 2026 and growth rate until 2026.
  • To classify and forecast global nanobodies market based on type, application, distribution channel, regional distribution, and company.
  • To identify dominant region or segment in the global nanobodies market.
  • To identify drivers and challenges for global nanobodies market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global nanobodies market.
  • To identify and analyze the profile of leading players operating in global nanobodies market.
  • To identify key sustainable strategies adopted by market players in global nanobodies market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global nanobodies market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Nanobodies manufacturing companies
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums, and alliances related to nanobodies market

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global nanobodies market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Global Nanobodies Market, By Type:

    • Mono-Specific
    • Multi-Specific
  • Global Nanobodies Market, By Application:
    • Acquired Thrombotic Thrombocytopenic Purpura (TTP)
    • Respiratory Syncytial Virus Infection
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
    • Oncology
    • Psoriasis
    • Chronic Kidney Diseases
    • Bone Disorders
    • Others
  • Global Nanobodies Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Nanobodies Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Europe
      • France
      • United Kingdom
      • Italy
      • Germany
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

      • South Africa
      • UAE
      • Saudi Arabia
      • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global nanobodies market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global nanobodies market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Nanobodies Market

4.    Voice of Customer

5.    Executive Summary

6.    Global Nanobodies Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Mono-Specific v/s Multi-Specific)

6.2.2.     By Application (Acquired Thrombotic Thrombocytopenic Purpura (TTP), Respiratory Syncytial Virus Infection, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Oncology, Psoriasis, Chronic Kidney Diseases, Bone Disorders, Others)

6.2.3.     By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

6.2.4.     By Region

6.2.5.     By Company (2020)

6.3.  Product Market Map

7.    North America Nanobodies Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type

7.2.2.     By Application

7.2.3.     By Distribution Channel

7.2.4.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Nanobodies Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Type

7.3.1.2.2.             By Application

7.3.1.2.3.             By Distribution Channel

7.3.2.     Mexico Nanobodies Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Type

7.3.2.2.2.             By Application

7.3.2.2.3.             By Distribution Channel

7.3.3.     Canada Nanobodies Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Type

7.3.3.2.2.             By Application

7.3.3.2.3.             By Distribution Channel

8.    Europe Nanobodies Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type

8.2.2.     By Application

8.2.3.     By Distribution Channel

8.2.4.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Nanobodies Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Type

8.3.1.2.2.             By Application

8.3.1.2.3.             By Distribution Channel

8.3.2.     United Kingdom Nanobodies Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Type

8.3.2.2.2.             By Application

8.3.2.2.3.             By Distribution Channel

8.3.3.     Italy Nanobodies Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Type

8.3.3.2.2.             By Application

8.3.3.2.3.             By Distribution Channel

8.3.4.     Germany Nanobodies Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Type

8.3.4.2.2.             By Application

8.3.4.2.3.             By Distribution Channel

8.3.5.     Spain Nanobodies Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Type

8.3.5.2.2.             By Application

8.3.5.2.3.             By Distribution Channel

9.    Asia-Pacific Nanobodies Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type

9.2.2.     By Application

9.2.3.     By Distribution Channel

9.2.4.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Nanobodies Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Type

9.3.1.2.2.             By Application

9.3.1.2.3.             By Distribution Channel

9.3.2.     India Nanobodies Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Type

9.3.2.2.2.             By Application

9.3.2.2.3.             By Distribution Channel

9.3.3.     Japan Nanobodies Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Type

9.3.3.2.2.             By Application

9.3.3.2.3.             By Distribution Channel

9.3.4.     South Korea Nanobodies Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Type

9.3.4.2.2.             By Application

9.3.4.2.3.             By Distribution Channel

9.3.5.     Australia Nanobodies Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Type

9.3.5.2.2.             By Application

9.3.5.2.3.             By Distribution Channel

10.  South America Nanobodies Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type

10.2.2.  By Application

10.2.3.  By Distribution Channel

10.2.4.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Nanobodies Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Type

10.3.1.2.2.           By Application

10.3.1.2.3.           By Distribution Channel

10.3.2.  Argentina Nanobodies Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Type

10.3.2.2.2.           By Application

10.3.2.2.3.           By Distribution Channel

10.3.3.  Colombia Nanobodies Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Type

10.3.3.2.2.           By Application

10.3.3.2.3.           By Distribution Channel

11.  Middle East and Africa Nanobodies Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Type

11.2.2.  By Application

11.2.3.  By Distribution Channel

11.2.4.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Nanobodies Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Type

11.3.1.2.2.           By Application

11.3.1.2.3.           By Distribution Channel

11.3.2.  UAE Nanobodies Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Type

11.3.2.2.2.           By Application

11.3.2.2.3.           By Distribution Channel

11.3.3.  Saudi Arabia Nanobodies Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Type

11.3.3.2.2.           By Application

11.3.3.2.3.           By Distribution Channel

11.3.4.  Kuwait Nanobodies Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Type

11.3.4.2.2.           By Application

11.3.4.2.3.           By Distribution Channel

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Novo Nordisk A/S

14.2.              Merck & Co., Inc.

14.3.              AbbVie, Inc.

14.4.              C.H. Boehringer Sohn AG & Ko. KG.

14.5.              Sanofi S.A. (Ablynx)

14.6.              Hybrigenics Services

14.7.              Beroni Group

14.8.              Shenzhen Kangti Co., Ltd. (Alphalife)

15.  Strategic Recommendations

16.   About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com